NEW YORK (GenomeWeb News) — BioMérieux will exclusively distribute AdvanDx’s diagnostic tests in the US, the French company said Tuesday. 
 
The tests, which use in situ hybridization technology, may be used to identify Staphylococcus aureus, Candida albicans, Enterococcus faecalis and other species of bacteria in fewer than five hours, the companies said.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.